Injection Procedure: Site Selection: Abdomen (2+ inches from navel), outer thigh, or back of upper arm
Tirzepatide: The Dual-Action GLP-1 and GIP Agonist Alternative Tirzepatide activates both GLP-1 and GIP receptorsa dual mechanism that some patients find more effective than GLP-1-only therapies
Both interventions induced similar weight loss (Fig
A higher-dose version of Wegovy, called Wegovy HD, offers a new option for weight loss
Patients should be counseled about the risk of hypoglycemia, particularly if taking concomitant insulin or sulfonylureas, though tirzepatide's glucose-dependent mechanism reduces this risk compared to older diabetes medications
The pharmaceutical company adds that people should take the new formulation the same way as before, so that people who were taking 3 mg should now take 1.5 mg, and so on